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We report the comparative proteomic characterization of the venoms of two related neotropical arboreal
pitvipers from Costa Rica of the genus Bothriechis, B. lateralis (side-striped palm pit viper) and B.
schlegelii (eyelash pit viper). The crude venoms were fractionated by reverse-phase HPLC, followed
by analysis of each chromatographic fraction by SDS-PAGE, N-terminal sequencing, MALDI-TOF mass
fingerprinting, and collision-induced dissociation tandem mass spectrometry of tryptic peptides. The
venom proteomes of B. lateralis and B. schlegelii comprise similar number of distinct proteins belonging,
respectively, to 8 and 7 protein families. The two Bothriechis venoms contain bradykinin-potentiating
peptides (BPPs), and proteins from the phospholipase A2 (PLA2), serine proteinase, L-amino acid oxidase
(LAO), cysteine-rich secretory protein (CRISP), and Zn2+-dependent metalloproteinase (SVMP) families,
albeit each species exhibit different relative abundances. Each venom also contains unique components,
for example, snake venom vascular endothelial growth factor (svVEGF) and C-type lectin-like molecules
in B. lateralis, and Kazal-type serine proteinase inhibitor-like proteins in B. schlegelii. Using a similarity
coefficient, we estimate that the similarity of the venom proteins between the two Bothriechis taxa
may be <10%, indicating a high divergence in their venom compositions, in spite of the fact that both
species have evolved to adapt to arboreal habits. The major toxin families of B. lateralis and B. schlegelii
are SVMP (55% of the total venom proteins) and PLA2 (44%), respectively. Their different venom toxin
compositions provide clues for rationalizing the distinct signs of envenomation caused by B. schlegelii
and B. lateralis. An antivenomic study of the immunoreactivity of the Instituto Clodomiro Picado (ICP)
polyvalent antivenom toward Bothriechis venoms revealed that L-amino acid oxidase and SVMPs
represent the major antigenic protein species in both venoms. Our results provide a ground for
rationalizing the reported protection of the ICP polyvalent antivenom against the hemorrhagic, coagulant,
defibrinating, caseinolytic and fibrin(ogen)olytic activities of Bothriechis (schlegelii, lateralis) venoms.
However, these analyses also evidenced the limited recognition capability of the polyvalent antivenom
toward a number of Bothriechis venom components, predominantly BPPs, svVEGF, Kazal-type inhibitors,
some PLA2 proteins, some serine proteinases, and CRISP molecules.
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Introduction
The suborder of snakes (Serpentes) of the reptilian order
Squamata, named for their scaly skin, includes about 3000
extant species placed in approximately 400 genera and 18
families (http://w.reptile-database.org/). The most generalized
phylogenetic view is that the group evolved from a family of
terrestrial lizards during the time of the dinosaurs in the
Jurassic period, about 200 million years (Myr) ago.1–3 Advanced
snakes (Caenophidia) arose in the Oligocene epoch 35-25 Myr
ago, but remained a small taxon until the tectonic plates drifted
apart from the equator and the cool climate pushed boids to
disappear from many ecological niches.4 Nowadays, snakes are
present worldwide except in the far north (Alaska and northern
Canada in North America, Greenland, Iceland, Ireland, extreme
northern Scandinavia and northern Russia in Eurasia), in the
far south (Antarctica and New Zealand) and some small oceanic
islands,5 where they have adapted to a diverse array of habitat
types, including terrestrial, arboreal, and aquatic ecosystems.
Colubrids, crotalines, and boids have evolved arboreal habits
independently.6 Adaptations to arboreal habits include the
development of cryptic color (mainly green or brown), nar-
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rowed skulls, large eyes and a prehensile tail. The prehensile
tail is not only used as an anchor when resting, but also when
the snake strikes out to grasp its prey, which commonly consists
of small birds, rodents, lizards and frogs. Arboreal snakes are
“sit-and-wait” predators, which passively wait for prey at
strategic hunting sites, likely selected through chemosensory
searching.7 Among predatory strategies, these snakes (especially
juveniles) employ what is known as “caudal luring”, which
consists in wiggling their tail in worm-like motions to encour-
age potential prey to move within striking range.7,8 Arboreal
snakes which do not present constriction behavior may feed
on small prey and are forced to hold onto it until the prey has
succumbed to the venom, and then swallowed. Campbell and
Solo´rzano9 mentioned that arboreal species such as Bothriechis
spp. were observed to almost invariably seize and hold their
prey. The disadvantages of holding dangerous prey may be
outweighed by the disadvantages of releasing and being unable
to relocate the prey in their arboreal environment.10
The Neotropics are abundant in small arboreal pitvipers.
Within Neotropical pitvipers, Bothriechis represents a mono-
phyletic basal genus11,12 comprising eight species of relatively
slender arboreal rattleless pitvipers.13,14 Bothriechis species are
largely nocturnal, consuming small rodents, frogs, lizards, small
birds, and occasionally bats. The name Bothriechis is derived
from the Greek bothros, meaning “pit”, and echis, meaning
“viper”, in reference to the prominent heat-sensitive pit that
lies between the nostril and the eye on either side of the face.
With this receptor, snakes can detect and accurately strike a
warm-blooded prey in absolute darkness, guided by the
infrared radiation that the prey generates.
Bothriechis lateralis (side-striped palm pit viper, also known
as “lora” in Costa Rica) is a pitviper species found in the
mountains of Costa Rica and western Panama at 850-980 m
altitude. Adult specimens may exceed 100 cm, but are usually
less than 80 cm in length.15 Like other fully arboreal snakes, B.
lateralis is a relatively slender and lightly built snake and has
a prehensile tail. Although B. lateralis venom seems to be of
moderate toxicity, bites may have dire consequences because
the snakes’ arboreal habits put them in contact with human’s
hands, arms and face.
Bothriechis schlegelii (eyelash pit viper, also known as
“bocaraca´” in Costa Rica), a relatively small species that rarely
exceed 75 cm in length found in mesic forest at elevations
almost from sea level to 2640 m altitude in Central and South
America,15 also causes a number of envenomation accidents
in Costa Rica.16 However, not much is known about Bothriechis
venoms except that signs and symptoms generally include
localized pain, progressive hemorrhagic edema, and, in some
cases, hemorrhagic blisters or hives, ecchymoses, and necro-
sis.17,18 It was also shown that the venom of B. schlegelii
induced significant myonecrosis in experimental animal
models.19,20 Gutie´rrez and Chaves20 studied the venoms of 10
Costa Rican species of pitvipers and found that those of B.
schlegelii (and Bothrops asper) had the greatest myonecrotic
activity, whereas the venoms of B. lateralis (and Cerrophidion
godmani) showed the strongest proteolytic activity toward
casein.
Venoms represent the critical innovation in ophidian evolu-
tion that allowed advanced snakes to transition from a me-
chanical (constriction) to a chemical (venom) means of sub-
duing and digesting large prey, and as such, venom proteins
have multiple functions including immobilizing, paralyzing,
killing and digesting prey. Given the central role that diet has
played in the adaptive radiation of snakes,21 venom thus
represents a key adaptation in the diversification of these
animals. On the other hand, the distinct signs and symptoms
of envenomation by snakebites of B. schlegelii and B. lateralis
suggest that these two species possess distinct toxin repertoires.
This would be in line with previous proteomic22–29 and
transcriptomic30–40 analyses showing that snake venom pro-
teins belong to only a few major protein families, though
venoms from different species depart from each other in the
composition and the relative abundance of their toxins. To
address this hypothesis, here we report the proteomic char-
acterization of the venoms of B. lateralis and B. schlegelii.
Treatment of snakebite envenomations is based on the
intravenous administration of monovalent or polyvalent anti-
venoms. Several antivenoms are produced in Latin America
using different venoms in the immunization schemes.41 Each
of these antivenoms is effective against envenomations by
snake venoms not included in the immunization protocol,
demonstrating the high degree of immunological cross reactiv-
ity between Central and South American crotaline snake
venoms. The polyvalent antivenom manufactured at the In-
stituto Clodomiro Picado (ICP, University of Costa Rica) using
a mixture of three snake (B. asper, Crotalus durissus durissus,
Lachesis stenophrys) venoms has been reported to neutralize
the lethality and the hemorrhagic, caseinolytic, coagulant,
defibrinating, fibrinolytic and fibrinogenolytic activities of a
number of venoms of Central and South American snakes.42–44
A second aim of this study was the evaluation of the immu-
noreactivity of the ICP polyvalent anti-(Crotalinae)-venom
toward Bothriechis venoms, that is, to investigate which specific
protein species within B. lateralis and B. schlegelii venoms are
effectively recognized and immunoprecipitated by the ICP
polyvalent snake antivenom.
Experimental Section
Isolation of Venom Proteins. Crude venoms of B. lateralis
and B. schlegelii were pooled from specimens collected in Costa
Rica and kept at the serpentarium of the Instituto Clodomiro
Picado, University of Costa Rica in San Jose´. For reverse-phase
HPLC separations, 2-5 mg of crude, lyophilized venom was
dissolved in 100 µL of 0.05% trifluoroacetic acid (TFA) and 5%
acetonitrile, and insoluble material was removed by centrifuga-
tion in an Eppendorff centrifuge at 13 000g for 10 min at room
temperature. Proteins in the soluble material were separated
using an ETTAN LC HPLC system (Amersham Biosciences) and
a Lichrosphere RP100 C18 column (250 × 4 mm, 5 µm particle
size) eluted at 1 mL/min with a linear gradient of 0.1% TFA in
water (solution A) and acetonitrile (solution B) (5% B for 10
min, followed by 5-15% B over 20 min, 15-45% B over 120
min, and 45-70% B over 20 min). Protein detection was at 215
nm and peaks were collected manually and dried in a Speed-
Vac (Savant). The relative abundances (% of the total venom
proteins) of the different protein families in the venoms were
estimated from the relation of the sum of the areas of the
reverse-phase chromatographic peaks containing proteins from
the same family to the total area of venom protein peaks.
Characterization of HPLC-Isolated Proteins. Isolated protein
fractions were subjected to N-terminal sequence analysis (using
a Procise instrument, Applied Biosystems, Foster City, CA) fol-
lowing the manufacturer’s instructions. Amino acid sequence
similarity searches were performed against the available databanks
using the BLAST program45 implemented in the WU-BLAST2
search engine at http://www.bork.embl-heidelberg.de. The mo-
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lecular masses of the purified proteins were determined by SDS-
PAGE (on 12 or 15% polyacrylamide gels) and by electrospray
ionization (ESI) mass spectrometry using an Applied Biosystems
QTrap 2000 mass spectrometer46 operated in Enhanced Multiple
Charge mode in the range m/z 600-1700.
In-Gel Enzymatic Digestion and Mass Fingerprinting. Pro-
tein bands of interest were excised from a Coomassie Brilliant
Blue-stained SDS-PAGE and subjected to automated reduction
with DTT and alkylation with iodoacetamide, and in-gel
digestion with sequencing grade bovine pancreatic trypsin
(Roche) using a ProGest digestor (Genomic Solutions) following
the manufacturer’s instructions. A total of 0.65 µL of the tryptic
peptide mixtures (total volume of ∼ 20 µL) was spotted onto a
MALDI-TOF sample holder, mixed with an equal volume of a
saturated solution of R-cyano-4-hydroxycinnamic acid (Sigma)
in 50% acetonitrile containing 0.1% TFA, dried, and analyzed
with an Applied Biosystems Voyager-DE Pro MALDI-TOF mass
spectrometer, operated in delayed extraction and reflector
modes. A tryptic peptide mixture of Cratylia floribunda seed
lectin (Swiss-Prot accession code P81517) prepared and previ-
ously characterized in our laboratory was used as mass calibra-
tion standard (mass range, 450-3300 Da).
Collision-Induced Dissociation Tandem Mass Spectrom-
etry (CID-MS/MS). For peptide sequencing, the protein digest
mixture was loaded in a nanospray capillary column and
subjected to electrospray ionization (ESI) mass spectrometric
analysis using a QTrap mass spectrometer (Applied Biosys-
tems)46 equipped with a nanospray source (Protana, Denmark).
Doubly- or triply charged ions of selected peptides from the
MALDI-TOF mass fingerprint spectra were analyzed in En-
hanced Resolution MS mode and the monoisotopic ions were
fragmented using the Enhanced Product Ion tool with Q0
trapping. Enhanced Resolution was performed at 250 amu/s
across the entire mass range. Settings for MS/MS experiments
were as follows: Q1, unit resolution; Q1-to-Q2 collision energy,
30-40 eV; Q3 entry barrier, 8 V; LIT (linear ion trap) Q3 fill
time, 250 ms; and Q3 scan rate, 1000 amu/s. CID spectra were
interpreted manually or using a licensed version of the
MASCOT program (http://www.matrixscience.com) against a
private database containing 927 viperid protein sequences
deposited in the Swiss-Prot/TrEMBL database (Knowledgebase
Release 12 of July 2007; http://us.expasy.org/sprot/; 212 in
Swiss-Prot, 715 in TrEMBL) plus the previously assigned
peptide ion sequences from snake venomics projects carried
out in our laboratory.22–25,27,28 MS/MS mass tolerance was set
to (0.6 Da. Carbamidomethyl cysteine and oxidation of me-
thionine were fixed and variable modifications, respectively.
Variation in Venom Composition between Bothriechis
Taxa. We used similarity coefficients to estimate the similarity
of venom proteins between taxa. These coefficients are similar
to the bandsharing coefficients used to compare individual
genetic profiles based on multilocus DNA fingerprints.47 We
defined the Protein Similarity Coefficient (PSC) between two
species “a” and “b” in the following way: PSCab ) [2(no. of
proteins shared between a and b)/(total number of distinct
proteins in a + total number of distinct proteins in b)] × 100.
We judged two proteins (listed in Tables 1–3) as being different
when they met one or more of these criteria: (1) had different
N-terminal sequences and/or distinct internal peptides se-
quences (derived from MS/MS data) corresponding to homolo-
gous regions; 2) had different peptide mass fingerprints; 3) were
of different sizes (judged by MALDI-TOF MS or SDS-PAGE) (For
these comparisons, two proteins were judged to differ in size
if they differed by more than our estimate of the 95% confi-
dence interval for particular sizing techniques (0.01% for ESI-
QTrap MS; 0.4% for MALDI-TOF MS derived masses, and +
1.4 kDa for SDS-PAGE-determined masses)); or (4) eluted in
different reverse-phase HPLC peaks.
Antivenomics. We have coined the term “antivenomics” for
the identification of venom proteins bearing epitopes recog-
nized by an antivenom using proteomic techniques. Polyvalent
(Crotalinae) antivenom (batch 3980506LQ, protein concentra-
tion of 55 mg/mL; expiry date: May 2009) was produced at ICP
by immunizing horses with a mixture of equal amounts of the
venoms of B. asper, C. durissus durissus, and L. stenophrys
obtained from adult specimens kept in captivity at the ICP
serpentarium.48 Whole immunoglobulins were purified by
caprylic acid precipitation.49 Two milligrams of whole venom
was dissolved in 70 µL of 20 mM phosphate buffer, pH 7.0,
mixed with 4 mg of purified polyvalent antivenom IgGs, and
incubated with gentle stirring for 1 h at 37 °C. Thereafter, 6
mg of rabbit anti-horse IgG antiserum (Sigma) in 350 µL of 20
mM phosphate buffer, pH 7.0, was added, and the mixture was
incubated for another 1 h at 37 °C. Immunocomplexes were
precipitated by centrifugation at 13 000 rpm for 30 min in an
Eppendorf centrifuge and the supernatant was submitted to
reverse-phase separation as described for the isolation of
venom proteins. HPLC-fractions were characterized as de-
scribed above. The control sample was subjected to the same
procedure except that antivenom IgGs were not included in
the reaction mixture.
Western Blot. The occurrence within the Polyvalent (Cro-
talinae) antivenom produced at ICP of antibodies directed
against antigenic determinants exhibited by B. schlegelii and
B. lateralis venom proteins, which may or may not be immu-
noprecipitated by the antivenomics approach described above,
was investigated by Western blot analysis. To this end, the
reverse-phase HPLC chromatographic fractions were electro-
phoresed in SDS-(10%)polyacrylamide gels under nonreduced
conditions followed by electrotransfer to nitrocellulose mem-
branes as described50 using a Bio-Rad minitransfer cell oper-
ated at 150 mA during 90 min. To assess transfer efficiency,
the nitrocellulose membranes were previsualized by reversible
Ponceau-S Red stain. Then, the membranes were incubated
in 1% bovine serum albumin in phosphate-buffered saline
(PBS; 0.12 M NaCl, 0.04 M sodium phosphate, pH 7.2) for 30
min at room temperature to block reactive sites, and the
membranes were subsequently incubated overnight at 4 °C
with either ICP polyvalent antivenom or normal equine serum,
diluted 1:1000 (for B. schlegelii) or 1:2000 (for B. lateralis) in
PBS. After washing four times with PBS containing 0.1%
albumin and 0.05% Tween-20, the membranes were incubated
with an anti-horse IgG-alkaline phospatase conjugate (Sigma)
diluted 1:1000 (for B. schlegelii) or 1:2000 (for B. lateralis),
during 2 h at room temperature. Finally, membranes were
washed four times as above, and color development was
performed by adding BCIP/NBT (Chemicon) substrate.
Results And Discussion
Characterization of the Venom Proteomes of B. lateralis
and B. schlegelii. The protein composition of the venoms of
B. lateralis and B. schlegelii was investigated using our snake
venomics approach,51 including fractionation of the crude
venoms by reverse-phase HPLC (Figures 1 and 2), analysis of
each chromatographic fraction by SDS-PAGE (Figures 3 and
4), N-terminal sequencing, and tryptic peptide MALDI-TOF
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mass fingerprinting (Tables 1 and 2). Protein fractions showing
single electrophoretic band, molecular mass, and N-terminal
sequence were straightforwardly assigned by BLAST analysis
(http://www.ncbi.nlm.nih.gov/BLAST) to a previously reported
Table 1. Assignment of the reverse-phase fractions of Bothriechis lateralisvenom, isolated as in Fig. 1, to protein families by
N-terminal Edman sequencing, mass spectrometry, and collision-induced fragmentation by nESI-MS/MS of selected peptide ions
from in-gel digested protein bands (separated by SDS-PAGE as in Fig. 2)a
peptide ion
HPLC
fraction Bl- N-terminal sequence molecular mass m/z z MS/MS-derived sequence protein family
1 N.D. 538.8 2 NPPAGPDVGPR Bradykinin-potentiating
peptide
2 N.D. 472.0 2 [NPPAGPDVGP]Na+ Bradykinin-potentiating
peptide
3, 4 n.p.
5 N.D. 855.8 2 (212.2)PGNPPAGPDVGPRXR Bradykinin-potentiating
peptide
6 N.D. 352.7 2 PPPISPP Bradykinin-potentiating
peptide
7 N.D. 621.8 2 ZKWDPPPISPP Bradykinin-potentiating
peptide
8 N.D. 249/131 kDa 685.1 2 ZVMPFMEVYSR svVEGF
9 SLLQFREMIKEETGK 14037 PLA2
10 SLLQFREMITKMTGK 13926 PLA2
11 VIGGDECNINEHR 48 kDa9/1 616.6 2 KVNDEDEQTR Serine proteinase
522.6 2 VVYPENVPK
756.8 2 VIGGDECNINEHR
12 SVDFDSESPRKPEIQ 24586 CRISP
13 IIGGDECNINEHRSL 38 kDa9/1 Serine proteinase
14 IIGGDECNINEHRFL 38 kDa9/1 Serine proteinase
15 IIGGDECNINEHRSL 38 kDa9/1 Serine proteinase
16 IIGGDECNINEHRSL 26 kDa9/1 538.6 2 SPDEDEQTR Serine proteinase
17 IIGGDECNINEHRSL 27 kDa9/1 538.6 2 SPDEDEQTR Serine proteinase
18 (V/I)(V/I)IGGDECNINEHR(S/F)L 27 kDa9/1 Serine proteinase
19 VIGGDECNINEHRFL 27.5 kDa9/1 Serine proteinase
20 VIGGDECNINEHRFL 26 kDa9/1 Serine proteinase
21 Heterogeneous 269/13-161 kDa 718.8 2 (229)QGXEQDTNYXK C-type lectin-like
22 Heterogeneous 56 kDa9/1 758.3 2 ETDYEEFXEXAR L-amino acid oxidase
583.1 2 KFWEDDGXR
269/13-161 kDa 640.6 3 DCPSDWSSYEGHCYR C-type lectin-like
718.8 2 (229)QGXEQDTNYXK
26 kDa9/1 756.9 2 VIGGDECNINEHRFL Serine proteinase
23, 24 DDPRNPLEECFRETD 56 kDa9/1 758.3 2 ETDYEEFXEXAR L-amino acid oxidase
583.1 2 KFWEDDGXR
25 N.D. 56 kDa9/1 758.3 2 ETDYEEFXEXAR L-amino acid oxidase
46 kDa9/1 657.8 2 YXEXAXXADHR PIII-metalloproteinase
38 kDa9/1 647.2 2 XNXXDYEVCR Serine proteinase
269/13-161 kDa 640.6 3 DCPSDWSSYEGHCYR C-type lectin-like
718.8 2 (229)QGXEQDTNYXK
26 kDa9/1 756.9 2 VIGGDECNINEHRFL Serine proteinase
26 Blocked 52 kDa9/1 579.1 2 KIPCAPEDVK PIII-metalloproteinase
670.2 2 YVEXFVXVVDQR
526.9 2 GNYYGYCR
27 Blocked 96 kDa9/481kDa 715.2 2 XAXVDNEXWSNR (PIII-metalloproteinase)2
657.8 2 YXEXAXXADHR
23 kDa9/1 555.9 2 TXDSFGEWR PI-metalloproteinase
28 Blocked 52 kDa9/1 502.1 2 GKGDFYCR PIII-metalloproteinase
641.2 2 XYDDNTQPCR
46 kDa9/1 657.8 2 YXEXAXXADHR PIII-metalloproteinase
673.3 3 (451.2)ECESGDCCDQCR
28 kDa9 555.9 2 TXDSFGEWR PI-metalloproteinase
26 kDa9/1 555.9 2 TXDSFGEWR PI-metalloproteinase
29 Blocked 23 kDa9/1 555.9 2 TXDSFGEWR PI-metalloproteinase
30 Blocked 96 kDa9/481kDa 715.2 2 XAXVDNEXWSNR (PIII-metalloproteinase)2
657.8 2 YXEXAXXADHR
30, 31 Blocked 42 kDa9/1 664.7 2 YIELVIVADHR PIII-metalloproteinase
673.3 3 (451.2)ECESGDCCDQCR
a X, Ile or Leu; Z, pyrrolidone carboxylic acid. Unless other stated, for MS/MS analyses, cysteine residues were carbamidomethylated. Molecular masses were
determined by electrospray-ionization ((0.02%) or MALDI-TOF (*) ((0.2%) mass spectrometry. Apparent molecular mass determined by SDS-PAGE of
non-reduced (9) and reduced (1) samples; n.p., nonpeptidic material found. M and m, denote mayor and minor products within the same HPLC fraction.
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protein or to a known protein family. Thus, the bradykinin-
potentiating peptides found in fractions Bs1-3, Bs6-7, Bs8 and
Bl6-7, and the C-type natriuretic peptide in Bs11 (Tables 2 and
3) are identical to peptides from Lachesis muta Q27J49 identi-
fied by MALDI-TOF MS in the crude venom of a specimen kept
in captivity at the serpentarium of the Fundac¸a˜o Ezequiel Dias
(Belo Horizonte, Brazil).52 In addition, B. schlegelii PLA2
molecules isolated in fractions Bs16, Bs18, Bs21/Bs24 (Table
2) may correspond to Lys-49 myotoxin II [P80963, Mcalc: 13534
Da],53,54 the basic N6-PLA2 [AY355168, Mcalc: 13786 Da],55 and
the acidic PLA2 [AAW92117, Mcalc: 13699 Da],
56 respectively.
These three PLA2 toxins represent the only protein sequences
from any Bothriechis species reported to date in the literature.
Fractions showing heterogeneous or a blocked N-terminal
residue were analyzed by SDS-PAGE and the bands of
interest were subjected to automated reduction, carbami-
domethylation, and in-gel tryptic digestion followed by
sequencing of selected doubly- and triply charged tryptic
peptide ions by collision-induced dissociation tandem mass
spectrometry (Tables 1 and 2). As expected from the rapid
amino acid sequence divergence of venom proteins evolving
under accelerated evolution,57–62 with a few exceptions, the
product ion spectra did not match any known protein using
the ProteinProspector (http://prospector.ucsf.edu) or the
MASCOT (http://www.matrixscience.com) search programs.
Although the lack of any complete snake genome sequence
is a serious drawback for the identification of venom
proteins, high-quality MS/MS production spectra usually
yielded sufficient de novo amino acid sequence information
derived from almost complete series of sequence-specific b-
and/or y-ions to unambiguously identify a homologue
protein in the current databases by BLAST analysis. The
Table 3. Overview of the Relative Occurrence of Proteins (in
Percentage of the Total HPLC-Separated Proteins) of the
Different Families in the Venoms of B. lateralis and B.
schlegelii
% of total venom proteins
protein family B. lateralis B. schlegelii
Bradykinin-potentiating peptides 11.1 13.4
svVEGF 0.5 –
Kazal-type inhibitors – 8.3
PLA2 8.7 43.8
CRISP 6.5 2.1
Serine proteinases 11.3 5.8
L-amino acid oxidase 6.1 8.9
C-type lectin-like 0.9 –
Zn2+-metalloproteinases 55.1 17.7
Figure 1. Reverse-phase HPLC separation of the venom proteins
from B. lateralis. Two milligrams of B. lateralis venom was
applied to a Lichrosphere RP100 C18 column, which was then
developed with the following chromatographic conditions: iso-
cratically (5% B) for 10 min, followed by 5-15% B for 20 min,
15-45% B for 120 min, and 45-70% B for 20 min. Fractions were
collected manually and characterized by N-terminal sequencing,
ESI mass spectrometry, tryptic peptide mass fingerprinting, and
CID-MS/MS of selected doubly- or triply charged peptide ions.
The results are shown in Table 1.
Figure 2. Reverse-phase HPLC separation of the venom proteins
from B. schlegelii. Two milligrams of B. schlegelii venom was
applied to a Lichrosphere RP100 C18 column, which was then
developed as in Figure 1. Fractions were collected manually and
characterized by N-terminal sequencing, ESI mass spectrometry,
tryptic peptide mass fingerprinting, and CID-MS/MS of selected
doubly- or triply charged peptide-ions. The results are shown
in Table 2.
Figure 3. SDS-PAGE of reverse-phase separated fractions from
the venom of B. lateralis. SDS-PAGE showing the protein
composition of the reverse-phase HPLC separated venom protein
fractions run under nonreduced (top panels) and reduced (bottom
panels) conditions. Molecular mass markers (S, in kDa) are
indicated at the left of each gel. Track numbering correspond to
HPLC fraction numbering shown in Figure 1. Protein bands were
excised and characterized by mass fingerprinting and CID-MS/
MS. The results are shown in Table 1.
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outlined snake venomics approach51 allowed us to assign
unambiguously to known protein families all the isolated
venom toxins representing more than 0.05% (w/w) of the
total venom proteins (Tables 1 and 2). In line with an array
of previous snake venomics studies,22–29 the proteins found
in the venoms of B. lateralis and B. schlegelii belong to only
a few families which are listed in Table 3. The venom
proteomes of B. lateralis and B. schlegelii comprise similar
number of distinct proteins belonging, respectively, to 8 and
7 types of toxins. The two Bothriechis venoms share brady-
kinin-potentiating peptides, and proteins from the PLA2,
serine proteinase, L-amino acid oxidase, CRISP, and Zn2+-
dependent metalloproteinase families, albeit each species
exhibits distinct relative abundances (Figure 5, Table 3). On
the other hand, each venom also contains unique compo-
nents, for example, svVEGF and C-type lectin-like molecules
in B. lateralis, and Kazal-type serine proteinase inhibitor-
like proteins in B. schlegelii.
B. schlegelii represents the sister taxon to all other Bothriechis
species, whereas B. lateralis segregates with Bothriechis bicolor
and Bothriechis marchi in the most recently isolated clade from
a common ancestor.63 Comparison of their venom proteomes
shows that the two Bothriechis species sampled have diverged
to a point where only few components (BPP Bl7 and Bs9; CRISP
Bl12 and Bs22; and PIII-SVMP Bl28 and Bs33) display identical,
or highly similar, structural features, such as N-terminal
sequence, molecular mass, and peptide mass fingerprint. Using
a similarity coefficient, we estimate that the similarity of the
venom proteins between these two Bothriechis taxa may be
<10%. This measure may give only a maximum estimate of
the similarity between the two venoms, since some of the
proteins that we judge to be highly similar would be found to
differ at one or more of the evaluation criteria if more complete
information were available. Furthermore, the large divergence
between the two Bothriechis species is also highlighted in Figure
5. The major toxin families of B. lateralis and B. schlegelii are
SVMP (55% of the total venom proteins) and PLA2 (44%),
respectively. The high degree of differentiation in the venom
proteome among congeneric taxa emphasizes unique aspects
of venom composition of related species of Bothriechis snakes
and points to a strong role for adaptive diversification via
natural selection as a cause of this distinctiveness, whose
possible physiological significance is discussed below.
A Novel Type of Venom Protein in B. schlegelii. N-terminal
sequence of the polypeptides isolated in fractions Bs10-13
display 57-75% similarity (48-62% identity) with the N-
terminal region of ovomucoid third domains from a large
number of avian species,64–66 including the absolute conserva-
tion of cysteine residues and the spacing between them.
Structurally, these protein domains belong to the Kazal-type
proteinase inhibitor fold (family PD000417 in the ProDom
protein domain family database, http://prodom.prabi.fr/
prodom/current/html/home.php). However, though a number
of Kazal-like domains harbor serine proteinase inhibitor activ-
ity, these protein scaffolds are also present in the extracellular
part of a number of proteins, which are not known to be
proteinase inhibitors. Clearly, experimental evidence is needed
to assess the biological activity of the Kazal-type proteins in
this venom.
Noteworthy, Kazal-type inhibitor-like proteins have not been
previously found in any snake venom reported to date. The
fact that Kazal-type inhibitors are not represented among the
restricted set of protein families that appear to have been
recruited into the venom proteome in an early stage of the
evolution of the venom systems in lizards and snakes67–70
indicates either that the repertoire of ancestral toxin families
is still incomplete or that recruitment of Kazal-type proteins
represents a more recent event in ophidian radiation. Multigene
phylogenetic reconstructions strongly support monophyly of
New Word crotalines.71,72 The diversity of New World pitvipers
arose over a period of 15-30 million years from a single
invasion of an Old World Eurasian species of the Gloydius-
Ovophis clade, which probably occurred during the early
Tertiary or late Cretaceous via the Bering Land Bridge.72 All
phylogenies indicate an early cladogenetic event splitting New
Word pitvipers into temperate (Agkistrodon, Crotalus, and
Sistrurus) and Neotropical (bothropoid genera and Lachesis)
groups.13 The lack of evidence for the occurrence of Kazal-type
proteins (or messengers) in the venom proteomes and tran-
scriptomes of species of genera Agkistrodon,34,35 Sistrurus,22,24
Bothrops,26,31–33 and Lachesis,37 would support the hypothesis
Figure 4. SDS-PAGE of reverse-phase separated fractions from
the venom of B. schlegelii. SDS-PAGE showing the protein
composition of the reverse-phase HPLC separated venom protein
fractions run under nonreduced (top panel) and reduced (bottom
panel) conditions. Molecular mass markers (S, in kDa) are
indicated at the left of each gel. Track numbering correspond to
HPLC fraction numbering shown in Figure 2. Protein bands were
excised and characterized by mass fingerprinting and CID-MS/
MS. The results are shown in Table 2.
Figure 5. Overall protein composition of Bothriechis venoms.
Comparison of the protein composition of the venoms of B.
lateralis(A) and B. schlegelii(B). BPP, bradykinin-potentiating;
PLA2, phospholipase A2; CRISP, cysteine-rich secretory protein;
C-lectin, C-type lectin-like protein; SVMP, snake venom metal-
loproteinase; LAO, L-amino acid oxidase; svVEGF, snake venom
vascular endothelial growth factor.
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of the recruitment event of these proteins along the speciation
of the Neotropical pitviper clade. Whether the occurrence of
Kazal-type proteins in B. schlegelii venom represents a genus-
specific recruitment event or are more widely distributed in
other snake clades deserves further investigation. On the other
hand, the presence of Kazal-type proteins in the venom of the
basal species, B. schlegelii, could indicate a species-specific
expression of this class of proteins, which may have played a
role in the early adaptive radiation of Bothriechis snakes,
loosing this function along the speciation of B. lateralis.
Clues for Understanding the Envenomation Profiles of
B. lateralis and B. schlegelii. Documentation of human ac-
cidents by Bothriechis snakebites is scarce. Indeed, we were
unable to find any report on the pathophysiology of human
envenomation by B. lateralis. On the other hand, initial
symptoms of B. schlegelii snakebite include localized pain,
progressive hemorrhagic edema, and, in some cases, hemor-
rhagic blisters or hives, ecchymoses, and necrosis.17,18,73 In
mice, the venom of B. schlegelii shows a higher toxicity than
that of B. lateralis (intravenous LD50 of 2 mg/kg for the former
and 4.8 mg/kg for the latter).74 Compared to a number of
Bothrops and Bothriopsis venoms, B. schlegelii venom exhibited
higher LAO activity.75 This observation can now be rationalized
by the high L-amino acid oxidase content of B. schlegelii venom
(Table 3). Other studies have shown that B. schlegelii venom
inflicts significant myonecrosis in experimental animal mo-
dels.19,20 Rabbits injected with B. lateralis venom developed a
conspicuous edema and hemorrhage in the muscle where
venom was administered, but no histological evidence of
myonecrosis was found.76 These distinct signs of envenomation
caused by B. schlegelii and B. lateralis venoms might be
explained by the large amounts of PLA2 in the former and the
high SVMP content of the latter (Table 3). Myotoxic PLA2
molecules account for most of the muscle necrosis that results
from envenomation by crotaline snakes.77,78 On the other hand,
SVMPs display a wide range of biological activities, including
hemorrhagic, fibrin(ogen)olytic, degradation of extracellular
matrix components, and activation of prothrombin and Factor
X, resulting in extensive local tissue damage and local and
systemic hemorrhage.79,80
Severe envenomation by B. asper, Bothrops punctatus, Por-
thidium nasutum, and B. schlegelii snakebites in Colombia were
characterized by local necrosis, local and systemic bleeding,
and/or hypotension or renal failure.81 The toxin composition
of the venoms of B. asper and P. nasutum have not been
reported. However, preliminary results from our laboratories
indicate that these venoms, like the B. schlegelii venom, contain
a large amount of bradykinin-potentiating peptides (BPPs,
Table 3). BPPs have been described as snake venom inhibitors
of angiotensin-converting enzyme, a dipeptidylcarboxypepti-
dase expressed in endothelial, epithelial and neuroepithelial
cells, which converts inactive angiotensin I into the potent
vasoconstrictor angiotensin II, and degrades bradykinin into
bradykinin (1-7) or bradykinin (1-5).82 BPPs prevent the
hypertensive effect of the angiotensin II and potentiate the
hypotensive effect of the circulating bradykinin. C-natriuretic
peptides elicit natriuretic, diuretic, and vasorelaxant activities.
Vasodilatation and hypotension contribute synergistically to
overall venom toxicity evoking the rapid diffusion of toxic
substances in the circulatory system and a hypotensive shock,
which is a major cause of death of the prey or victim of viper
snakebites. Rapid immobilization due to BPP-induced hy-
potension and other mechanisms may represent an adaptation
of Bothriechis species, and possibly other arboreal “sit-and-
wait” predators for outweighting the threat of holding large,
dangerous prey, and for restraining it from escaping during the
swallowing process.
Antivenomics: Bothriechis Venom Components Immun-
odepleted by the Polyvalent ICP Antivenom. Panel B of Figure
6 displays a reverse-phase separation of B. lateralis venom
proteins recovered in the soluble fraction after incubation of
the venom with polyvalent (Crotalinae) antivenom followed by
immunoprecipitation with rabbit anti-horse IgG antiserum. In
parallel, the immunoreactivity of the reverse-phase separated
fractions from a nontreated venom sample or a control sample
(venom incubated with PBS followed by rabbit anti-horse IgG
antiserum and centrifugation), shown in panel A of Figure 6,
was assessed by Western blotting (Figure 7). Both approaches
Figure 6. Immunodepletion of B. lateralis venom proteins by the
polyvalent antivenom produced at Instituto Clodomiro Picado
(ICP). Panels A and B show, respectively, reverse-phase separa-
tions of soluble B. lateralis venom proteins recovered after
incubation of the venom with rabbit anti-horse IgG antiserum
(control sample), and with polyvalent (Crotalinae) antivenom
followed by rabbit anti-horse IgG antiserum and immunopre-
cipitation. HPLC fractions labelled with asterisks in panel A were
quantitatively immunodepleted from the venom sample incu-
bated with the polyvalent antivenom, whereas fractions labelled
in panel B with numbers (following the same numbering as in
Figure 1) were not affected at all (1-12, 20), or were only partially
recognized (13-17, 22), by the antivenom (see Figure 7). The
insert in panel B shows an SDS-PAGE analysis of -mercapto-
ethanol-reduced fractions a-g. CID-MS/MS of tryptic peptide ions
from these fractions (601.72+: LSVPTSEWQR; 545.62+: VVSTLPI-
AHQDWLR; 621.63+: TTPAVLDSDGSYFLYSK) identified them as
rabbit IgGs.
Proteomics of Bothriechis Snake Venoms research articles
Journal of Proteome Research • Vol. 7, No. 6, 2008 2453
yielded essentially the same information: fractions 1-12 and
20 were not recognized by antivenom antibodies; fractions
13-22, although displaying immunoreactivity toward the an-
tivenom, were only partially immunodepleted from the venom;
and fractions 23-31 were quantitatively immunodepleted from
the venom and show strong immunoreactivity by Western
blotting.
L-Amino acid oxidase and the different PI- and PIII SVNPs
represent the major immunodominant proteins in B. lateralis
venom, whereas serine proteinases and C-type lectin-like
molecules were only partially immunoprecipitated from the
venom. Together, these proteins represent about 73% (SVMPs
+ LAO, 61%) of the total B. lateralis venom components. On
the other hand, components not recognized by the antivenom
comprise all the bradykinin-potentiating peptides, the single
svVEGF and CRISP proteins, and the two PLA2 molecules found
in B. lateralis venom, as well as a 48 kDa serine proteinase
(Table 1). Together, these components represent about 27%
of the total venom proteins (Table 3).
Similar results were obtained with the venom of B. schlegelii
(Figure 8). In Western blots, the polyvalent antivenom recog-
nized, although very weakly, proteins Bs 13-17 (PLA2 mol-
ecules) and with higher avidity Bs 29-34 (LAO and SVMPs).
The latter toxins were quantitatively immunodepleted from the
venom, whereas PLA2 Bs-17 was only partly immunoprecipi-
tated (Figure 8). These proteins represent about 30% of the total
B. schlegelii venom proteins. The bradykinin-potentiating pep-
tides, Kazal-type inhibitors, and the CRISP protein within B.
schlegelii venom were not recognized by antivenom IgGs by
neither approach (Western blot or immunoprecipitation in
solution). A previous work showed that the polyvalent ICP
antivenom was able to neutralize the indirect hemolytic activity
of PLA2 molecules of crude B. lateralis and B. schlegelii venoms,
albeit requiring a relatively high antivenom concentration.83
Differences in the employed methodologies may explain varia-
tions in immunorecognition/neutralization of PLA2s between
the previous report and the present investigation.
Considering the central role that venom has played in the
adaptive radiation of snakes and the underlying diversifying
selection pressure to maintain high levels of variation in venom
genes through accelerated evolution,21,62 it is not surprising that
the ICP polyvalent antivenom, raised against the venoms of B.
asper, C. durissus durissus, and L. stenophrys binds to, and
immunoprecipitates, a limited set of Bothriechis venom com-
ponents. The structure of the nonrecognized venom proteins
may have diverged to an extent where the antivenom does not
display significant affinity toward some Bothriechis venom
proteins. In line with this hypothesis, snake venom serine
proteinase and PLA2 genes are known to be members of large
multigene families.58,60,61 Positive Darwinian selection and
neofunctionalization has been shown to be common in snake
venom PLA2 genes.
84 On the other hand, the bradykinin-
potentiating peptides (BPPs) NPPAGPDVGPR (Bl-1) and ZK-
Figure 7. Western blot analysis of the reactivity of polyvalent
antivenom with B. lateralis venom proteins. Venom proteins
separated by reverse-phase HPLC as in Figure 6 were electro-
phoresed in SDS-(10%)polyacrylamide gels under nonreduced
conditions (A), electrotransferred to nitrocellulose membranes,
and probed with the ICP polyvalent antivenom (B). Protein
bands 8-12, 20 not recognized by the antiserum are high-
lighted in panel A.
Figure 8. Immunodepletion of B. schlegelii venom proteins by
the ICP polyvalent antivenom. Panels A and B show, respec-
tively, reverse-phase separations of soluble B. schlegelii
venom proteins recovered after incubation of the venom with
rabbit anti-horse IgG antiserum (control sample), and with the
ICP polyvalent antivenom followed by rabbit anti-horse IgG
antiserum and immunoprecipitation. HPLC fractions labelled
with asterisks in panel A were quantitatively immunodepleted
from the venom sample incubated with the antivenom, whereas
fractions labelled in panel B with numbers (following the same
numbering as in Figure 2) were not affected (1-16, 18-28),
or were only partially immunodepleted (Bs17), by the anti-
venom. Nonlabeled late-eluting peaks correspond to rabbit IgG
molecules, as in Figure 6.
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WDPPPISPP (Bl-7) (Table 1), and TPPAGPDVGPR (Bs-3), ZW-
SHKGWPPRPQIPP (Bs-6), ZKKWPPGHHIPP (Bs-7) and ZKWDPP-
ISPP (Bs-9) (Table 2) are conserved in the sequence of the BPP-
and C-natriuretic peptide precursor molecule [Q27J49] from
L. stenophrys,85 suggesting that at least the short BPPs may
escape the immune response of the hyperimmunized horses,
probably since their low molecular mass (Mr) values are below
the general limits for immunogenicity.
Our results reveal a limitation of the ICP polyvalent anti-
venom in binding to, and thus neutralizing, the low Mr venom
protein components. The failure of snake antivenoms to
recognize specific components of the venom used for hyper-
immunization has been previously reported.86,87 A study on
the spectrum of venom proteins from the Australian snakes
Pseudonaja affinis affinis, Pseudonaja textilis and Pseudonaja
nuchalis recognized and neutralized by a brown snake anti-
venom,87 raised in horse against the venom of P. textilis by
the Australian Commonwealth Serum Laboratories (CSL),
highlighted a deficiency in the interaction between this anti-
venom and protein constituents of the Pseudonaja sp. snakes
of 6 kDa to <32 kDa, predominantly PLA2 proteins and
R-neurotoxins.
Concluding Remarks
The aims of the present work were to characterize through
a snake venomics approach51 the protein composition of the
arboreal neotropical pitvipers B. lateralis and B. schlegelii, and
to investigate which protein species within these snake venoms
are effectively recognized and immunoprecipitated by the ICP
polyvalent antivenom. For the latter aim, we have coined the
term “antivenomics”. A major aim of the combined venomic
and antivenomic studies is the understanding of the antivenom
specificity as a first step toward the development of improved
antivenoms with a more complete toxin neutralization profile.
The venomics results reveal that the major toxin families of B.
lateralis and B. schlegelii are SVMP (55% of the total venom
proteins) and PLA2 (44%), respectively, providing clues for
rationalizing the distinct signs of envenomation caused by these
Bothriechis species. In addition, the antivenomic characteriza-
tion of the venoms provides a ground for the reported protec-
tion of the ICP polyvalent antivenom against the lethal,
hemorrhagic, coagulant, defibrinating, fibrin(ogen)olytic and
caseinolytic activities of Bothriechis (schlegelii, lateralis)
venoms,42–44 which are associated with serine proteinases and/
or SVMPs.88 Our study also predicts the limited neutralization
capability of the polyvalent antivenom toward a number of
Bothriechis venom components, predominantly BPPs, svVEGF,
Kazal-type inhibitors, some PLA2s, some serine proteinases, and
CRISP molecules. The potential therapeutic implications of
these findings are presently unknown since the biological
effects of the nonimmunoprecipitated venom fraction have not
been studied.
Snakebite envenomation constitutes a highly relevant public
health hazard in Central and South America which has an
impact in terms of mortality and morbidity. Antivenoms should
ideally neutralize all venom components playing a role in the
pathophysiology of envenomation. Antivenoms can be im-
proved by using proteomic and molecular approaches, such
as the selection of candidate epitopes for structure-based
design of antitoxin antibodies.89 In addition, the design of DNA
constructs encoding a string of relevant and widespread
distributed epitopes has been successfully used for immuniza-
tion.90 Current antivenoms contain an immunoglobulin pool
of unknown antigen specificity, including antibodies to non-
toxic components and non-neutralizing antibodies against
toxin epitopes. Therefore, the venomic and antivenomic tools
employed in this work may become useful for a more precise
knowledge of the most relevant and abundant venom compo-
nents and for the identification of toxins not recognized by
antivenoms, thus, paving the way for the design of more
effective immunotherapeutics.
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